CareLit · DOI-Nachweis · Aktuelle Neurologie
PET guided chemotherapy – monitoring metabolic effects of temozolomide chemotherapy in malignant gliomas and of long-term adjuvant chemotherapy in patients with glioblastoma
DOI 10.1055/s-2006-953186
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN. Galldiks, L.W. Kracht, L. Burghaus, R. Ullrich, K. Kesper, W.D. Heiss, K. Herholz, A.H. Jacobs, W.F. Haupt
ZeitschriftAktuelle Neurologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: One general trend in oncology is to monitor biological effects of chemotherapy. [11C]methionine (MET)-PET may be a helpful tool to differentiate responders from non-responders and may provide valuable information for making treatment decisions, especially in non-responders. Therefore, MET-PET might have the potential to predict clinical outcome. A further focus of interest is the monitoring of metabolic effect…
Zitieren
Zitierempfehlung
N. Galldiks, L.W. Kracht, L. Burghaus, R. Ullrich, K. Kesper, W.D. Heiss, K. Herholz, A.H. Jacobs, W.F. Haupt (2006) PET guided chemotherapy – monitoring metabolic effects of temozolomide chemotherapy in malignant gliomas and of long-term adjuvant chemotherapy in patients with glioblastoma. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2006-953186
Mit CareLit weiterarbeiten